Bill Would Require Medicare to Cover New Breakthrough Devices for at Least 4 Years
The bill is designed to provide Medicare patients faster access to innovative technology approved by the FDA.
The bill is designed to provide Medicare patients faster access to innovative technology approved by the FDA.
According to the FDA’s recently-released annual report, only 135 devices received the designation last year, versus 213 in 2021.
In draft guidance, the FDA is proposing that medical device makers will need to consider how accessible their products are to underserved populations.
Medical device makers will have to show that their products will be accessible to disadvantaged populations.
The CDRH Total Product Life Cycle Advisory Program Pilot aims to improve the FDA authorization process for medical devices.